Inhibition of HERG1 K+ channels by the novel second-generation antihistamine mizolastine

British Journal of Pharmacology

Volumn 131, Issue 6, 2000, Pages 1081-1088

  Taglialatela, M ^a   Pannaccione, A ^a   Castaldo, P ^a   Giorgio, G ^a   Annunziato, L ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Antihistamines; Arrhythmias; Drug cardiotoxicity; Mizolastine; Potassium channels

Indexed keywords

ASTEMIZOLE; COMPLEMENTARY DNA; GENE PRODUCT; HISTAMINE H1 RECEPTOR ANTAGONIST; MIZOLASTINE; POTASSIUM CHANNEL; PROTEIN HERG1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARDIOTOXICITY; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION CONSTANT; EMBRYO; GENETIC TRANSFECTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMAN CELL; IC 50; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOPUS;

EID: 0033696898     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703654     Document Type: Article

References (47)

1. + current with a cell cycle-dependence governs the resting potential of neuroblastoma cells
2. 1 receptors in the rodent
3. Regulation of potassium channels by nonsedating antihistamines
4. + current highly conserved in tumors of different histogenesis: A selective advantage for cancer cells?
5. 1 receptor antagonist mizolastine on cardiac potassium and sodium currents
6. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria
7. Study of cardiac repolarization in healthy volunteers performed with mizolastine, a new H1-receptor antagonist
8. Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine
9. Torsade de pointes after astemizole overdose
10. Assessment of the anticholinergic effect of the new antihistamine mizolastine in healthy subjects
11. Cardiotoxic effect with convulsions in terfenadine overdose
12. QT interval monitoring during clinical studies with mizolastine, a new H1 antihistamine
13. Molecular determinants of dofetilide block of HERG K+ channels
14. A novel potassium channel with delayed rectifier properties isolated from rat brain by expression cloning
15. + current in rod inner segments
16. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membranae patches
17. Molecular physiology and pharmacology of HERG. Single channel currents and block by dofetilide
18. Efficacy and safety of mizolastine in seasonal allergic rhinitis. The Rhinase Study Group
19. Functional expression of a rat homologue of the voltage gated ether a go-go potassium channel reveals differences in selectivity and activation kinetics between the Drosophila channel and its mammalian counterpart
20. Torsade de pointes occurring in association with terfenadine use
21. Oncogenic potential of LAG K(+) channels
22. Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers
23. HERG, a primary human ventricular target of the non sedating antihistamine terfenadine
24. 1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine
25. A mechanistic link between an inherited and acquired cardiac arrhythmia: HERG encodes the I(Kr) potassium channel
26. + current: Differential sensitivity to block by class III antiarrhythmic agents
27. Second-generation antihistamines: A comparative review
28. High affinity open channel block by dofetilide of HERG expressed in a human cell line
29. Terfenadine: A review of its pharmacodynamic properties and therapeutic efficacy
30. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole
31. + channels as pharmacological targets: Present and future implications
32. 1 receptor blocker cetirizine compared with other second-generation antihistamines
33. Cardiotoxic potential and CNS effects of first-generation antihistamines
34. + channels
35. A double blind placebo controlled multicentered study on mizolastine, a new non- sedative H1-receptor antagonist, in patients suffering from perennial allergic rhinoconjunctivitis
36. HERG, a human inward rectifier in the voltagegated potassium channel family
37. Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers
38. A family of potassium channel genes related to eag in Drosofila and mammals
39. Mechanism of the cardiotoxic action of terfenadine
40. Cardiac actions of antihistamines
41. + channel, erg
42. Attenuation of the slow component of delayed rectification, action potential prolongation, and triggered activity in mice expressing a dominant-negative Kv2 alpha subunit
43. Characterization of an ultrarapid delayed rectifier potassium channel involved in canine atrial repolarization
44. Chemistry underlying the cardiotoxicity of antihistamines
45. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature